Intranasal salmon calcitonin	Placebo	Visual Analogue Scale score during the first post-fracture period	8566	8747	Our findings demonstrate a higher decrease of pain during the first post-fracture period (10 days) between calcitonin and placebo group (Calcitonin: -50% vs Placebo: -16.7% p=0.028)
Intranasal salmon calcitonin	Placebo	Baseline demographic characteristics	7394	7567	There is no statistical difference between the two groups in demographics (Table 1). Also, there is homogeneity between the two groups regarding demographic characteristics.
Intranasal salmon calcitonin	Placebo	Baseline demographic characteristics	7394	7467	There is no statistical difference between the two groups in demographics
